Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy

Medical Physics

Volumn 32, Issue 3, 2005, Pages 720-725

  Stavreva, N A ^a   Warkentin, B ^a   Stavrev, P V ^a   Fallone, B G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMISSION CONTROL PROTOCOL;

DOSE FRACTIONATION; EXPERIMENTAL ANIMALS; EXTERNAL RADIOTHERAPY; NON-STATIONARY DIFFUSIONS; RADIOSENSITIVITY PARAMETERS; TIME-DEPENDENT EXPRESSION; TUMOR CONTROL PROBABILITY; TUMOR RESPONSE;

TUMORS;

ARTICLE; BEAM THERAPY; CANCER CONTROL; CELL POPULATION; DATA ANALYSIS; DERIVATIZATION; DOSE RESPONSE; DYNAMICS; OXYGENATION; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; RADIOTHERAPY; RHABDOMYOSARCOMA; SENSITIZATION; TUMOR GROWTH;

EID: 15744387357     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1861523     Document Type: Article

References (19)

1. N. A. Stavreva, P. V. Stavrev, B. Warkentin, and B. G. Fallone, "Investigating the effect of cell repopulation on the tumor response to fractionated external radiotherapy," Med. Phys. 30, 735-742 (2003).
2. M. Zaider and G. N. Minerbo, "Tumour control probability: A formulation applicable to any temporal protocol of dose delivery," Phys. Med. Biol. 45, 279-293 (2000).
3. J. J. Fischer and J. E. Moulder, "Steepness of dose-response curve in radiation-therapy-Theoretical considerations and experimental results," Radiology 117, 179-184 (1975).
4. J. F. Fowler, J. Denekamp, P. W. Sheldon, A. M. Smith, A. C. Begg, S. R. Harris, and A. L. Page, "Optimum fractionation in X-ray treatment of C3H mouse mammary tumours," Br. J. Radiol. 47, 781-789 (1974).
5. H. E. Johns and J. R. Cunningham, The Physics of Radiology, 4th ed. (Thomas, Springfield, IL, 1983).
6. J. Denekamp, A. Dasu, and A. Waites, "Vasculature and microenvironmental gradients: The missing links in novel approaches to cancer therapy?," Adv. Enzyme Regul. 38, 281-299 (1998).
7. A. S. Ljungkvist, J. Bussink, P. F. Rijken, J. H. Kaanders, A. J. van der Kogel, and J. Denekamp, "Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas," Int. J. Radiat. Oncol., Biol., Phys. 54, 215-218 (2002).
8. A. C. Begg, H. Janssen, D. Sprong, I. Hofland, G. Blommestijn, J. A. Raleigh, M. Varia, A. Balm, L. Van Velthuyzen, P. Delaere, R. Sciot, and K. M. G. Haustermans, "Hypoxia and perfusion measurements in human tumors-initial experience with pimonidazole and IUdR," Acta Oncol. 40, 924-928 (2001).
9. J. Nilsson, B. K. Lind, and A. Brahme, "Radiation response of hypoxic and generally heterogeneous tissues," Int. J. Radiat. Biol. 78, 389-405 (2002).
10. J. Denekamp and A. Dasu, "Inducible repair and the two forms of tumour hypoxia-time for a paradigm shift," Acta Oncol. 38, 903-918 (1999).
11. A. Dasu, I. Toma-Dasu, and M. Karlsson, "Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia," Phys. Med. Biol. 48, 2829-2842 (2003).
12. A. Brahme and A. K. Agren, "Optimal dose distribution for eradication of heterogeneous tumours," Acta Oncol. 26, 377-385 (1987).
13. P. Kallman, A. Agren, and A. Brahme, "Tumour and normal tissue responses to fractionated non-uniform dose delivery," Int. J. Radiat. Biol. 62, 249-262 (1992).
14. R. J. Yaes, "Tumor heterogeneity, tumor size, and radioresistance," Int. J. Radiat. Oncol., Biol., Phys. 17, 993-1005 (1989).
15. D. Collett, Modelling Binary Data (Chapman & Hall, New York, 1991).
16. P. Stavrev, A. Niemierko, N. Stavreva, and M. Goitein, "The application of biological models to clinical data," Phys. Medica 17, 71-82 (2001).
17. W. H. Press, B. P. Flannery, S. A. Teukolsky, and W. T. Vetterling, Numerical Recipes (Cambridge University Press, Cambridge, 1986).
18. P. Okunieff, D. Morgan, A. Niemierko, and H. D. Suit, "Radiation dose-response of human tumors," Int. J. Radiat. Oncol., Biol., Phys. 32, 1227-1237 (1995).
19. S. A. Roberts and J. H. Hendry, "A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity," Int. J. Radiat. Oncol., Biol., Phys. 41, 689-699 (1998).